Literature DB >> 2260675

A novel epithelial cell from neonatal rat lung: isolation and differentiated phenotype.

P E Roberts1, D M Phillips, J P Mather.   

Abstract

A novel epithelial cell from normal neonatal rat lung has been isolated, established, and maintained for multiple passages in the absence of serum, without undergoing crisis or senescence. By careful manipulation of the nutrition/hormonal microenvironment, we have been able to select, from a heterogeneous population, a single epithelial cell type that can maintain highly differentiated features in vitro. This cell type has characteristics of bronchiolar epithelial cells. A clonal line, RL-65, has been selected and observed for greater than 2 yr in continuous culture. It has been characterized by ultrastructural, morphological, and biochemical criteria. The basal medium for this cell line is Ham's F12/Dulbecco's modified Eagle's (DME) medium plus insulin (1 micrograms/ml), human transferrin (10 micrograms/ml), ethanolamine (10(-4) M), phosphoethanolamine (10(-4) M), selenium (2.5 x 10(-8) M), hydrocortisone (2.5 x 10(-7) M), and forskolin (5 microM). The addition of 150 micrograms/ml of bovine pituitary extract to the defined basal medium stimulates a greater than 10-fold increase in cell number and a 50- to 100-fold increase in thymidine incorporation. The addition of retinoic acid results in further enhancement of cell growth and complete inhibition of keratinization. We have demonstrated a strategy that may be applicable to isolating other cell types from the lung and maintaining their differentiated characteristics for long-term culture in vitro. Such a culture system promises to be a useful model in which to study cellular events associated with differentiation and proliferation in the lung and to better understand the molecular mechanisms involved in these events.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260675     DOI: 10.1152/ajplung.1990.259.6.L415

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Stem cells of the respiratory epithelium and their in vitro cultivation.

Authors:  M Emura
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-01       Impact factor: 2.416

2.  Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.

Authors:  Timothy G Whitsett; Emily Cheng; Landon Inge; Kaushal Asrani; Nathan M Jameson; Galen Hostetter; Glen J Weiss; Christopher B Kingsley; Joseph C Loftus; Ross Bremner; Nhan L Tran; Jeffrey A Winkles
Journal:  Am J Pathol       Date:  2012-05-23       Impact factor: 4.307

3.  Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.

Authors:  Raphael Nemenoff; Amy M Meyer; Tyler M Hudish; Anthony B Mozer; Amy Snee; Shuh Narumiya; Robert S Stearman; Robert A Winn; Mary Weiser-Evans; Mark W Geraci; Robert L Keith
Journal:  Cancer Prev Res (Phila)       Date:  2008-10

4.  Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9.

Authors:  Xue-Qing Wang; Howard Li; Vicki Van Putten; Robert A Winn; Lynn E Heasley; Raphael A Nemenoff
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

5.  A tissue culture model of murine gammaherpesvirus replication reveals roles for the viral cyclin in both virus replication and egress from infected cells.

Authors:  Francine M Scott; Samuel H Speck
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

6.  Isolation of cancer stem like cells from human adenosquamous carcinoma of the lung supports a monoclonal origin from a multipotential tissue stem cell.

Authors:  Jennie P Mather; Penelope E Roberts; Zhuangyu Pan; Francine Chen; Jeffrey Hooley; Peter Young; Xiaolin Xu; Douglas H Smith; Ann Easton; Panjing Li; Ezio Bonvini; Scott Koenig; Paul A Moore
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.